Vineet Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vineet Laboratories Ltd. on BSE

Search Inside the pdf :

Vineet Laboratories Ltd.

17 Apr 2025

34.08

-0.93%

Corp. Note

Vineet Laboratories Ltd - 543298 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyVineet Laboratories Ltd 2CIN NO.L24304TG2016PLC112888 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 39.07 4Highest Credit Rating during the previous FY - 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ramesh Kumar Bandari Designation: Company Secretary cum Compliance Officer EmailId: cs@vineetlabs.co.in Name of the Chief Financial Officer: Satyanarayana Raju Bhupathiraju Designation: Whole time director cum CFO EmailId: bhsnraju6969@gmail.com Date: 17/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Vineet Laboratories Ltd.

16 Apr 2025

34.08

-0.93%

Company Update

Vineet Laboratories Ltd - 543298 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the fourth quarter and the financial year ended on March 31, 2025.

pdf

Vineet Laboratories Ltd.

25 Mar 2025

34.08

-0.93%

SAST

Vineet Laboratories Ltd - 543298 - Closure of Trading Window

BSE India

This is to inform that the trading window for dealing in the securities of the company will remain closed from 01st April, 2025 till 48 hours after the announcement of Standalone Audited Financial Results for the Fourth Quarter and Financial Year ending on 31st March, 2025.

pdf

Vineet Laboratories Ltd.

15 Feb 2025

34.08

-0.93%

Company Update

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are hereby submitting the Newspaper Advertisement in Financial Express (English language) and Nava Telangana (Telugu language) regarding the Un-audited Standalone financial results for the third quarter and nine months ended on December 31, 2024,

pdf

Vineet Laboratories Ltd.

13 Feb 2025

34.08

-0.93%

Corp. Note

Vineet Laboratories Ltd - 543298 - Integrated Filing (Financial)

BSE India

The Board considered and approved un-audited financial results along with limited review report of the company for the third quarter and nine months ended on December 31, 2024.

pdf

Vineet Laboratories Ltd.

12 Feb 2025

34.08

-0.93%

Result

Vineet Laboratories Ltd - 543298 - Outcome Of Board Meeting Held On Wednesday, November 13, 2024 …

BSE India

This is to inform you that the Board of Directors in their meeting held on Wednesday, February 12, 2025 has considered and approved un-audited standalone financial results along with limited review report of the company for the third quarter and nine months ended on December 31, 2024.

pdf

Vineet Laboratories Ltd.

12 Feb 2025

34.08

-0.93%

Board Meeting

Vineet Laboratories Ltd - 543298 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

The Board of Directors of the company in its meeting held today Le., on February 12, 2025 has considered and approved Un-audited Standalone Financial Results along with limited review report of the Company for the third quarter and nine months ended on December 31, 2024.

pdf

Vineet Laboratories Ltd.

04 Feb 2025

34.08

-0.93%

Board Meeting

Vineet Laboratories Ltd - 543298 - Board Meeting Intimation for Considering And Approving The Unaudited Standalone …

BSE India

Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve the unaudited standalone financial results of the company for the third quarter ended on December 31, 2024 along with limited review report.

pdf

Vineet Laboratories Ltd.

09 Jan 2025

34.08

-0.93%

Company Update

Vineet Laboratories Ltd - 543298 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

pdf

Vineet Laboratories Ltd.

26 Dec 2024

34.08

-0.93%

SAST

Vineet Laboratories Ltd - 543298 - Closure of Trading Window

BSE India

This is to inform that the trading window for dealing in the securities of the company will remain closed from 01st January, 2025 till 48 hours after the announcement of Standalone Unaudited Financial Results for the Third Quarter and Nine Months ending on 31st December, 2024.

pdf

VOTE: Is Vineet Laboratories Ltd. worth buying?

18 Votes:

Buy 88.89%

Sell 5.56%

Hold 5.56%